Company Insights
Eli Lilly races to fend off competitors in weight-loss drug market
Eli Lilly bulks up on supply and lawsuits to ward off competition in the booming weight loss market
Section
Eli Lilly
Cigna
Immune to market slump, these four major healthcare stocks are on an expansion kick
The economy may be ailing but dominant healthcare stocks have so far resisted infection, and look poised to continue thriving.
Insulin Price Caps and Tough Litigation Won’t Bury Big Pharma
Federal legislative overhaul of the healthcare sector is throwing a wrench into Big Pharma’s growth this fall, but companies are expected to weather the storm in a market hungry for new drug therapies.